Search

everythinglearnresearchcommunity

for

Search:↓

Patients with systemic lupus erythematosus and hair loss had non-scarring alopecia with fewer hair follicles, and direct immunofluorescence did not help identify lupus.

Sorafenib may cause hair loss in a way similar to alopecia areata.

Avoiding allergens can improve skin and hair conditions in adults with allergic reactions.

Permanent hair loss after a stem cell transplant can be a sign of chronic immune system attack on the scalp.

Lichen planopilaris can unusually affect only the face, causing pigmentation and scarring.

Methotrexate caused a rare skin rash in a rheumatoid arthritis patient, which resolved after stopping the drug.

A woman with discoid lupus improved with treatment after being misdiagnosed with a different hair loss condition.

Hair loss improved with treatment and successful transplant.

FFA and FAPD might be related or stages of the same disease.

Trichoscopy is crucial for accurately diagnosing fibrosing alopecia in pattern distribution.

The man was diagnosed with lupus and improved with treatment.

Chronic lupus and frontal fibrosing alopecia can occur together, but their connection is unclear.

Autoimmune hepatitis in children often affects girls and can be treated successfully with medication.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

A man with a rare skin condition and a new gene mutation developed high calcium levels due to his treatment.

Women with lupus experienced non-scarring hair loss with fewer hair follicles, and the test for lupus in hair was not helpful.

Patients with systemic lupus erythematosus and hair loss had fewer hair follicles and non-scarring alopecia; direct immunofluorescence was not helpful in diagnosing lupus in these cases.

Patients with SLE experienced non-scarring hair loss with fewer hair follicles, and DIF did not help identify lupus.

AVT is highly conserved and may have antimicrobial properties.

Some African American women experience central scalp hair loss, often linked to a history of fungal scalp infection.

The document concludes that better targeted treatments are needed for wound healing, and single-cell technologies may improve cell-based therapies.

Frontal fibrosing alopecia is a hair loss condition in postmenopausal women, similar to lichen planopilaris, with ineffective treatments.

Chemotherapy can cause various skin reactions, with hair loss being the most common, and proper diagnosis and treatment of these reactions are important.

Mutations in the SRD5A3 gene cause a new type of glycosylation disorder by blocking the production of a molecule necessary for protein glycosylation.

The conclusion is that accurate diagnosis of different types of hair loss requires good teamwork between skin doctors and lab experts.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

FFA is more common in postmenopausal women, can affect younger women, and may stabilize over time.

Alopecia areata causes hair loss, has no cure, and various treatments exist.

The document concludes that more research is needed to better understand and treat primary cicatricial alopecias, and suggests a possible reclassification based on molecular pathways.

Patients with certain skin symptoms and high ANA titers should be monitored for potential systemic lupus.